Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TRIO |
| Upstream (Parents) |
|---|
| (<<) PTP4A3 → TRIO |
| (<<) TRIM2 → TRIO |
| (<<) TRAF5 → TRIO |
| (<<) LST1 → TRIO |
| (<<) SNX10 → TRIO |
| (<<) EFNA4 → TRIO |
| Downstream (Children) |
|---|
| TRIO → IQCC (>>) |
| TRIO → FMO6P (>>) |
| TRIO → CRH (>>) |
| TRIO → DAGLA (>>) |
| TRIO → FLRT1 (>>) |
| TRIO → RETN (>>) |
| TRIO → SLC5A2 (>>) |
| TRIO → ALX3 (>>) |
